A patient-centred decision on inhaler device will help ensure optimised disease management. Device choice may be considered on the basis of patient acceptability, ease of use, environmental impact and cost.
It is essential to specify inhaler strength and dose. Branded products may need stated so that individuals receive the correct device they are trained to use.
The propellant used in metered dose inhalers (MDIs) are powerful greenhouse gases which have global warming potential. The Scottish Government aim to reduce emissions from inhaler propellants by 70% by 2028.1 The formulary outlines the carbon footprint per puff of each inhaler, as either Low (<35 g CO2e) or High (≥35 g CO2e)2.
Before changing medication or increasing/decreasing dose consider the following points:
1. Review inhaler technique – every time!
2. Check exposure to trigger factors.
3. Review compliance with treatment – consider modifiable factors.
References
- NHS Scotland climate emergency and sustainability strategy: 2022-2026 https://www.gov.scot/publications/nhs-scotland-climate-emergency-sustainability-strategy-2022-2026/ [accessed 02/05/2023]
- PrescQIPP Bulletin 295: Inhaler carbon footprint https://www.prescqipp.info/our-resources/bulletins/bulletin-295-inhaler-carbon-footprint/ [accessed 02/05/2023]